Long-term experiences with IV ketamine and esketamine for depression
About this title
Read the official source — NCT06725277Understand this study
What is this study about?
This study evaluates the effectiveness of Spravato for people with depression.
What will I do during this study?
This is an observational study of people starting or continuing clinician-prescribed IV ketamine or intranasal esketamine (Spravato). Researchers follow treatment use, acceptability, satisfaction, effectiveness and safety over time; the registry describes a five-year study, but does not specify how long each person participates.
- Listed locations
- Milford and 7 more locationsSee all locations and recruitment
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 450
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Observational
- Intervention type
- Drug
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT06725277
- Official title
Show the full official title
Comparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression: The OBSERVE Protocol
Recruitment & locations
Milford · New Haven · Atlanta
5 more locations
- Ann Arbor
- Moore
- Nashville
- Bellaire
- Seattle
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the effectiveness of Spravato for people with depression.
Who is behind this study?
The study sponsor is Yale University, a university.
Does this study involve medication?
Yes. The study involves medication, including Spravato and IV Ketamine.
Is this study still recruiting?
The registry lists this study as recruiting.
